Novo Nordisk A/S (NVO)

Novo Nordisk Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	214,166	384,855	461,550	304,426	256,201	162,142
Market Cap Growth	-53.73%	-16.62%	51.61%	18.82%	58.01%	18.73%
Enterprise Value	224,868	382,368	458,427	302,773	252,890	158,629
Last Close Price	49.05	84.34	100.64	65.24	53.42	32.87
PE Ratio	13.71	27.45	37.19	38.16	35.07	23.41
PS Ratio	4.32	9.55	13.40	11.97	11.90	7.77
PB Ratio	8.02	19.32	29.21	25.38	23.68	15.58
P/TBV Ratio	21.53	85.58	67.43	65.10	60.74	23.12
P/FCF Ratio	20.71	37.56	37.45	31.75	34.42	21.39
P/OCF Ratio	11.01	22.92	28.58	26.86	30.45	18.99
EV/Sales Ratio	4.54	9.49	13.31	11.91	11.74	7.60
EV/EBITDA Ratio	8.65	18.78	27.97	25.98	25.93	16.48
EV/EBIT Ratio	9.32	19.69	29.53	27.87	27.92	17.83
EV/FCF Ratio	21.75	37.32	37.20	31.57	33.97	20.93
Debt / Equity Ratio	0.60	0.72	0.25	0.31	0.38	0.16
Debt / EBITDA Ratio	0.61	0.69	0.24	0.31	0.41	0.17
Debt / FCF Ratio	1.53	1.39	0.33	0.39	0.55	0.23
Asset Turnover	0.69	0.74	0.84	0.81	0.83	0.94
Inventory Turnover	1.22	1.20	1.26	1.29	1.24	1.16
Quick Ratio	0.53	0.52	0.62	0.67	0.65	0.64
Current Ratio	0.78	0.74	0.82	0.90	0.86	0.94
Return on Equity (ROE)	71.47%	80.77%	88.07%	72.00%	71.24%	69.70%
Return on Assets (ROA)	21.11%	22.41%	23.55%	21.69%	21.81%	25.01%
Return on Capital (ROIC)	42.81%	46.03%	53.89%	45.74%	43.27%	49.84%
Return on Capital Employed (ROCE)	55.30%	56.30%	72.30%	62.80%	62.30%	72.50%
Earnings Yield	7.61%	3.64%	2.69%	2.62%	2.85%	4.27%
FCF Yield	4.83%	2.66%	2.67%	3.15%	2.90%	4.67%
Dividend Yield	2.45%	1.88%	1.39%	1.36%	1.49%	2.27%
Payout Ratio	33.57%	43.71%	37.96%	45.57%	45.05%	47.75%
Buyback Yield / Dilution	0.46%	0.71%	1.10%	1.34%	1.58%	1.63%
Total Shareholder Return	2.96%	2.58%	2.48%	2.70%	3.07%	3.90%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q